Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04436575
Other study ID # TMarkarian/Ecuhda
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date July 1, 2020
Est. completion date November 1, 2021

Study information

Verified date June 2020
Source SUD Association pour le Développement de la Recherche et de lEnseignement
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Acute Gastrointestinal (GI) Bleeding are a common chief complaint among Emergency Department. The mortality rate for Lower GI Bleeding is 3.9%. While the mortality rate can be as high as 10% for Upper GI Bleeding. Most existing scores take into account hemodynamic parameters such as systolic blood pressure or heart rate. Studies have shown that hemodynamic instability only develops late in the course of a bleed, as evidenced by a blood depletion of 30 to 40% of the total blood volume. Currently, few studies have examined the value of echocardiography in the management of patients presenting for Acute GI Bleeding in the Emergency Department. The main objective of this study is to show whether simple ultrasound parameters can, combined with clinico biological parameters, predict in an early manner the evolution of the patient presenting to the Emergency Department for Acute Gastrointestinal Bleeding.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 150
Est. completion date November 1, 2021
Est. primary completion date July 1, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Primary reason for emergency Department admission is acute gastrointestinal bleeding

Exclusion Criteria:

- Pregnant or breastfeeding women

- Persons not benefiting from a social security scheme

- Persons deprived of liberty

- Patient participates in another study

- The patient is in a period of exclusion determined by a previous study.

- The patient is under legal protection, guardianship or trusteeship.

- Patient refuses to participate

- It proves impossible to give informed information about the subject matter

- The patient is not fluent in French.

Study Design


Intervention

Device:
Point-of-care ultrasound
Point-of-care ultrasound prognostic performance : echocardiography mainly

Locations

Country Name City State
France MARKARIAN Thibaut Marseille

Sponsors (1)

Lead Sponsor Collaborator
SUD Association pour le Développement de la Recherche et de lEnseignement

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Correlation of ultrasound parameters with the occurrence of adverse events The primary outcome was to determine the correlation of echocardiography parameters to detect adverse events (AEs). Echocardiography parameters included signs of severe hypovolemia (end systolic left ventricular obliteration and/or complete inspiratory collapse of the inferior vena cava and/or E velocity < 0.7 m/s). Adverse events were defined as blood transfusion, therapeutic intervention to control haemorrhage (endoscopic, radiologic or surgical hemostasis), rebleeding and in-hospital mortality. 1 day
Secondary Echocardiography and clinical scores Correlation of echocardiographic signs of severe hypovolemia (end systolic left ventricular obliteration and/or complete inspiratory collapse of the inferior vena cava and/or E velocity < 0.7 m/s) with existing clinical scores (Glasgow-Blatchford bleeding score and Rockall score).
The Glasgow-Blatchford bleeding score includes measurements of hemoglobin in grams per deciliter, blood urea nitrogen in millimoles per liter, initial systolic blood pressure in millimeters of mercury, sex, heart rate in beats per minute, melena present, recent syncope, hepatic disease history and cardiac failure present.
The Rockall score includes measurement of age, shock present, comorbidities, diagnosis and major stigmata of recent hemorrhage.
1 day
Secondary Other ultrasound parameters with the occurrence of adverse events The correlation of other echocardiography parameters (visual assess of the ejection fraction (in percentage) and E/A ratio (represents the ratio of peak velocity blood flow from left ventricular relaxation in early diastole = the E velocity in meter per second, to peak velocity flow in late diastole caused by atrial contraction = the A velocity in meter per second) and E' velocity (in centimeter per seconds) and ratio E/E' (ratio between early mitral inflow velocity = the E velocity in centimeter per second and mitral annular early diastolic velocity = the E' velocity in centimeter per second) and subaortic velocity time index (VTI in centimeter) with the occurrence of adverse events. 1 day
See also
  Status Clinical Trial Phase
Recruiting NCT05550649 - Safety and Efficacy of Prophylactic Arterial Embolization in the Treatment of Angiography-negative Acute Upper Gastrointestinal Bleeding N/A
Not yet recruiting NCT06188585 - Randomized Trial of UI-EWD vs. Conventional Endoscopic Therapy for Bleeding Ulcers N/A
Completed NCT01727453 - Compare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding. Phase 4